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Abstract 
Purpose: To investigate the hypolipidemic potential of the 70 % ethanol fruit extract of Prosopis 
cineraria (Fabaceae) (Et. PCF) in triton-induced hyperlipidemia in rats. 
Methods: Et-PCF was obtained by pulverizing whole dried fruits and extracting with 70 % ethanol. Adult 
Sprague Dawley rats were divided into six groups of six rats each. The groups were namely normal 
control, hyperlipidaemic control, standard drug-treated (simvastatin 4 mg/kg), and three Et-PCF (200, 
400 and 600 mg/kg, respectively)-treated groups. Apart from normal control, all other groups received a 
single dose of triton (200 mg/kg, i.p.) exactly 30 min after a dose of the standard drug and Et-PCF for 
the induction of hyperlipidemia. Twenty four hours after triton injection, hyperlipidemia was confirmed by 
collecting blood samples from all the rats and testing for serum lipid profile. Antioxidant activity, in the 
form of inhibition of lipid peroxidation, was determined along with chromatographic analysis. Moreover, 
molecular docking study of β-sitosterol (active constitute of PCF) was performed with Farnesoid X 
receptor. 
Results: Triton-induced hyperlipidemia group showed significant increase in total cholesterol, low 
density lipoprotein cholesterol (LDL), very low density lipoprotein cholesterol (VLDL) , triglyceride, 
atherogenic index and decreased high density lipoprotein cholesterol (HDL), compared to normal 
control group. Et-PCF treated groups showed reduction in serum cholesterol, triglyceride, VLDL and 
LDL levels compared to triton treated control group. Extract at the dose of 200 mg/kg significantly 
reduce serum cholesterol (p < 0.01) and serum LDL (p < 0.01). At the dose level of 400 mg/kg and 600 
mg/kg extract is effective to significantly reduce serum cholesterol (p < 0.05), triglyceride (p < 0.05), 
VLDL (p < 0.05), LDL (p < 0.05) and atherogenic index (p < 0.05) and these results are almost 
equivalent to those of standard drug simvastatin. Furthermore, antioxidant activity, i.e., IC50 of Et-PCF 
was 58.33 μg/ml. Molecular docking score of β-sitosterol for Farnesoid X receptor was -8.32 kcal/mol, 
suggesting excellent binding conformation of Et-PCF to receptor molecules. 
Conclusion: The findings suggest that Prosopis cineraria may be beneficial for preventing 
hyperlipidaemic complications by its anti-hyperlipidemic and antioxidant activities. 
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Hypercholesterolemia is an excessive high 
plasma cholesterol level and a strong risk factor 
for negative cardiovascular events such as 
obesity, diabetes and hypertension [1,2]. 
Atherogenesis is a multifactor process that 
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includes oxidative modification of LDL which 
further leads to atherosclerosis [3].  
 
Research, in recent years, has focused on 
dietary antioxidants from plant-derived sources to 
normalize elevated levels of cholesterol 
atherogenous fractions, mainly LDL, and of 
glucose in an attempt to reduce the 
cardiovascular risk [4,5]. Hyperlipidemia is a 
clinical condition characterized by elevation in 
blood lipid levels. Increase in blood lipid levels 
stimulates atherosclerosis and leads to 
hardening of arteries. This hampers normal blood 
circulation and results in fatal cardiovascular 
disease (CVD) [6].  
 
A logical strategy to prevent or treat 
atherosclerosis and reduce the incidence of 
cardiovascular disease events is to target 
hyperlipidaemia and oxidative stress by diet 
and/or drug intervention. Therefore, there is an 
urgent need to have drugs with lipid lowering and 
antioxidant activities with no side effects. 
Previously conducted studies demonstrated 
natural products derived from different parts of 
various plants possess significant hypolipidemic 
potential [7-10]. 
 
Prosopis cineraria, a plant belonging to the family 
Fabaceae), is known as ‘Khejri’ in many parts of 
India. It is used as a therapeutic agent in greater 
parts of India, Burma and Sri Lanka [11]. 
Literature suggests that, the bark is used in the 
treatment of asthma, bronchitis, dysentery, 
leucoderma, leprosy, muscle tremors and piles 
[12,13]. Several bioactive compounds such as 
flavonoids, alkaloids, phenolic contents, free 
amino acids, spicigerin, prosogerin A, B, C and 
D, β-sitosterol and vitamins have been isolated 
from different parts of the plant [14,15]. The 
presence of these bioactive compounds suggest 
Prosopis cineraria may possess hypolipidemic 
and antioxidant potentials like other previously 
studied medicinal plants [7-10]. Fruits of Prosopis 
cineraria are an important constituent of the diet 
of tribal people from Satpuda region of 
Maharashtra, India and these people are free 
from cardiovascular complaints.  
 
Hence, we hypothesized that oral treatment with 
Prosopis cineraria fruits extract probably 
possesses hypolipidemic effect in triton-induced 
hyperlipidemia. As the antioxidant from plant 
derived sources help to reduce elevated levels of 
cholesterol [4,5], we also investigated the 
antioxidant potential of Et-PCF. Docking study of 
β-sitosterol for FXR was undertaken by in-silico 
to evaluate binding conformation of Et-PCF to 






Sprague Dawley rats (180-200 g) of either sex 
were obtained from college animal house of R.C. 
Patel Institute of Pharmaceutical Education and 
Research (RCPIPER), Shirpur, India. They were 
housed under standard laboratory conditions and 
were fed commercial rat feed (Lipton India Ltd., 
Mumbai, India) and previously boiled water 
allowed to cool, ad libitum. Purpose of using 
boiled water was to maintain strict hygienic 
conditions and avoid chances of infection. The 
experimental protocol was approved by IAEC 
and CPCSEA, Department of forest and 
environment, Government of India, New Delhi 





Triton WR 1339 (Loba- chemie Ltd, India), 
cholesterol, triglyceride, HDL kits (BEACON 
Diagnostic Pvt. Ltd, Gujarat, India), ethanol 
procured from college central store (RCPIPER) 
were used in this study. All the solvents used 
were analytical reagent AR and high 
performance liquid chromatography (HPLC) 
grade. 
 
Preparation of Prosopis cineraria extract 
 
The plant material was collected between 8.00-
10.00 AM in the month of July-2013 at Satpuda 
region, Maharastra, India. Authentication was 
made by Professor Dr. L. K. Kshirsagar, 
Taxonomist, Department of Botany, S.S.V.P.S’s 
L. K. Dr. Ghogre Science College, Dhule, North 
Maharashtra University, Jalgaon. A voucher 
specimen (RCPIPER/Pharmacology/25-2013) 
has been kept in the Department of 
Pharmacology of Institute for further reference. 
Fruits were separated, cleaned, washed and air-
dried. The dried fruits were pulverized by passing 
through 40 mesh sieve and extracted with 70 % 
ethanol using a Soxhlet extractor. The extract 
was concentrated in vacuum evaporator below 
40 °C. 
 
Phytochemical investigation and 
chromatographic analysis of extract 
 
The ethanol extract was subjected to various 
tests for various phytochemical constituents as 
previously described by Kokate [17]. High 
performance liquid chromatography (HPLC) 
analyses was carried out on the extract using  
Shimadzu class LC-10AT HPLC system, 
equipted with Rheodyne 7725i injector fitted with 
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a 20 μl loop, column oven, and a photodiode 
array (PDA) detector, using Column Exsil ODS 
C-18 column (250 mm × 4.6 mm). The results 
were analyzed by chromquest version 3.0 
software on Pentium computer (Hewlett 
Packard). Samples were eluted in 
Acetonitrile:water (90:10) as the mobile phase. 
Flow rate was constantly kept at 0.3 ml/min. and 
detection was carried out at 210 nm. 
 
Acute oral toxicity study 
 
Albino female mice weighing 25-30 g were used 
for acute oral toxicity study. Acute toxicity study 
was carried out as per Organization for 
Economic Co-operation and Development 
(OECD) Guideline 425 “Up & Down” method [18]. 
The test drug was found to be safe up to the 
dose of 5000 mg/kg body weight hence 1/10th of 
this dose was taken as an effective dose (500 
mg/kg). The doses selected were 200, 400 and 
600 mg/kg. 
 
Assessment of hypolipidemic activity  
 
Sprague Dawley rats were selected for the 
experimental model. The rats were fed with the 
standard diet and water ad libitum before the 
experiment. Room temperature was maintained 
between 20 and 30 oC and relative humidity of 40 
– 60 %. The weight of the selected rats was 
between 180 and 200 g. 36 rats were divided into 
6 groups of 6 rats per group. According to the 
body weight of individual rat, 200 mg/kg of triton 
was injected intraperitoneally [19]. 
 
Group 1 - Normal saline 1ml orally/animal. 
 
Group 2 - Triton WR 1339 (200 mg/kg)  
 
Group 3 - Triton WR 1339 (200 mg/kg) + 
Simvastatin 4 mg/kg orally  
 
Group 4 - Triton WR 1339 (200 mg/kg) + Et-PCF 
200 mg/kg orally 
 
Group 5 - Triton WR 1339 (200 mg/kg) + Et-PCF 
400 mg/kg orally 
 
Group 6 - Triton WR 1339 (200 mg/kg) + Et-PCF 
600 mg/kg orally 
 
Blood samples were collected from normal rats 
and taken for analysis. For the treatment groups, 
the extract/simvastatin was given orally 30 min 
prior to triton injection. 3 ml of blood sample was 
collected from all the rats by making retro-orbital 
puncture both before triton injection (0 h) and 
after triton injection (24 h) [7]. Blood serum was 
separated by centrifugation at 3000 rpm and 
analyzed for lipid profile. 
 
Determination of LDL cholesterol and 
atherogenic index 
 
LDL cholesterol (LDLC) was calculated as in Eq 
1 [20]. 
 
LDLC = TC – HDLC – VLDL ……………….. (1) 
 
where TC, HDLC and VLDL are  total 
cholesterol, HDL cholesterol and VLDL 
cholesterol, respectively.  
 
Atherogenic index (AI) was computed as in Eq 2 
[21]. 
 
AI = {(TC – HDLC)/HDLC} ………………… (2) 
 
Evaluation of antioxidant activity  
 
Anti-lipid peroxidation  
 
The mixture containing 0.5 ml of rat liver 
homogenate, 1 ml of 0.15 ml potassium chloride 
(KCl) and 0.5 ml of different concentrations (20 
%, 40 %, 60 %, 80 %, 100 %) of drug extract 
were prepared. Lipid peroxidation was initiated 
by adding 100 µl of 1 mM ferric chloride. The 
reaction mixture was incubated for 30 min at 37 
°C. After incubation 2 ml of ice-cold 0.25 N 
Hydrochloric acid (HCl) containing 15 % 
trichloroacetic acid (TCA) and 0.38 % 
thiobarbituric acid (TBA) and 0.2 ml of 0.05 % 
butylated hydroxytoluene (BHT) was added in 
the reaction mixture. This reaction mixture was 
heated for 60 min at 80 °C, cooled and 
centrifuged at 5000 g for 15 min. The 
absorbance of the supernatant was measured 
spectrophotometrically (Microplate reader power 
wave XS2, BIOTEK, USA) at 532 nm against a 
blank, which contained all reagents except liver 
homogenate and drug. Identical experiments 
were performed to determine the normal (without 
drug and ferric chloride) and induced (without 
drug) lipid peroxidation levels in the tissue. 
Percent anti-lipid peroxidation effect (ALP) was 
calculated as in Eq 3 [8]. 
 
ALP (%) = {(Af – As)/Af – An}100 ……….. (3) 
 
where Af, As and An are the absorbance of ferric 
chloride, test sample and normal sample, 
respectively. 
 
Reducing power assay 
 
The reducing power of the ethanolic extract of 
Prosopis cineraria was determined on the ability 
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of antioxidants to form colored complex with 
potassium ferricyanide. Various concentrations of 
the extract (10, 20, 40, 60 and 80 µg/mL) were 
mixed with 2.5 mL phosphate buffer (pH 6.6) and 
2.5 mL potassium ferricyanide (1 %). The mixture 
was incubated at 50 °C for 20 min. 2.5 mL TCA 
(10 %) was added to it and centrifuged at 3000 
rpm for 10 min. The supernatant (2.5 mL) was 
mixed with 2.5 mL of water and 0.5 mL of FeCl3 
(0.1 %) were added to it, and the absorbance 
was measured spectrophotometrically at 700 nm. 
Increased absorbance of the reaction mixture 
indicates increased reducing power [22]. 
 
Molecular docking study 
 
The molecular docking tool, GLIDE (Schordinger 
Inc, USA, 2009), was used for ligand docking 
studies into the FXR binding pocket. The crystal 
structures of FXR was obtained from protein data 
bank (PDB ID: 1OSH) [23]. The protein 
preparation was carried out using ‘protein 
preparation wizard’ in Maestro 9.0 in two steps, 
preparation and refinement. After ensuring 
chemical correctness, water molecules in the 
crystal structures were deleted and hydrogens 
were added, where they were missing. Using 
OPLS 2005 force field energy of crystal structure 
was minimized [24]. This is forcefield in 
Schordinger 9.0, which is used to optimize the 
geometry of protein crystal structure and beta 
sitosterol. After optimization, we docked beta 
sitosterol into the cavity of FXR to check the 
binding mode. 
 
Grids were defined centering them on the ligand 
in the crystal structure using the default box size. 
The ligands were built using maestro build panel 
and prepared by Ligprep 2.2 module which 
produce the low energy conformer of ligands 
using OPLS 2005 force field. The low energy 
conformation of the ligands was selected and 
was docked into the grid generated from protein 
structures using standard precision (SP) docking 
mode. The final evaluation is done with glide 
score (docking score) and single best pose is 




The data are presented as mean ± standard 
error of mean (SEM). All data were analyzed 
using one-way analysis of variance (ANOVA) 
with Dunnet’s post hoc test by Graph Pad Prism 





The ethanol extract tested positive for flavonoids, 
tannins, saponins, sterols and phenolic 
compounds. HPLC analysis also confirmed the 
presence of these phytoconstituents. The HPLC 
chromatogram of the extract is shown in Fig 1. 
The HPLC finger print for standard β-sitosterol 
showed a single peak while the extract showed 
six peaks at the wavelength of 210 nm. 
 
In vivo hypolipidemic effect of Et-PCF on lipid 
profile 
 
The effect of Et-PCF on serum lipid profile in 
control and treatment groups at different doses 
are shown in Table 1. The acute injection of 
TWR caused a significant increase in lipid levels 
when compared with Group I rats. Group VI 
showed a significant (p < 0.01) reduction in 
cholesterol (26.67 %), triglyceride (26.52 %), LDL 
(54.93 %) and VLDL (26.60 %) levels, where as 
significant increase (p < 0.05) was observed in 
HDL (11.53 %) after treatment of Et-PCF when 




Fig. 1: HPLC fingerprint of ethanolic extract of Prosopis cineraria 
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The AI was also significantly (p < 0.01) 
decreased (53.34 %) in Group VI after treatment. 
In group IV at the minimum dose of 200 mg/kg 
Et-PCF significantly reduce both serum 
cholesterol (p < 0.01) and serum LDL (p < 0.01) 
as compared to group II.  We observed a dose-
dependent reduction of lipid profile and maximum 
antihyperlipidemic effect (p < 0.01) was seen in 
Group V (400 mg/kg of Et-PCF) and VI (600 
mg/kg of Et-PCF) when compared to Group II. 
This effect of reduction in lipid profile and 
maximum antihyperlipidemic effect is almost 
equivalent to group III who received standard 




In the present study, the ethanol extract showed 
potent inhibition of lipid peroxidation induced by 
Iron/ADP/Ascorbate complex in rat liver 
homogenate, IC50 value was 58.33 μg/ml. It 
showed dose dependent inhibition of lipid 
peroxidation. Standard ascorbic acid showed 
IC50 of 50.92 μg/mL (Fig 2). 
 
The measurement of reductive ability was done 
by Fe3+-Fe2+ transformation in the presence of 
ethanol extract and standard antioxidant, 
ascorbic acid [25]. The reducing power is 
associated with antioxidant activity. As shown in 
Fig. 3, the ethanolic extract showed a reducing 
power comparable with the standard at the 
highest concentration i.e. at 80 μg/ml. 
 
















Fig 2: Effect of Prosopis cineraria on lipid peroxidation 
activity in rat liver homogenate 
 



















1ml/animal 81.54±2.99 74.04±2.97 14.81±0.59 23.25±3.56 48.58±1.327 0.68±0.08 
Triton only 
200 120.9±2.82
### 132.3±2.57### 26.47±0.51### 71.51±2.16### 41.12±1.58## 1.95±0.09## 
Simvastatin 
4+ TWR 84.79±2.63** 92.63±2.94** 18.53±0.58** 26.70±2.86** 48.41±0.914** 0.75±0.06** 
Et-PCF 
200 + TWR 109.7±2.82* 121.9±3.79 24.39±0.75 60.50±3.29* 41.04±1.63 1.69±0.13 
Et-PCF 
400 +TWR 101.9±2.73** 107.4±1.84** 21.47±0.36** 53.04±1.61** 40.70±1.41 1.50±0.04** 
Et-PCF 
600+TWR 88.55±2.68** 97.15±2.65** 19.43±0.53** 32.77±2.96** 46.48±1.25* 0.91±0.07** 
Values are expressed as mean ± SEM (n = 6); data were analyzed by one-way ANOVA followed by Dunnet’s 
test; # denotes compared to normal control group, *p < 0.01 = very significant; **p < 0.05=significant, compared 
with triton-treated rats (Group II) 
 
 
                Ascorbic acid;         Ethanol extract 
 
Fig 3: Effect of Prosopis cineraria on in-vitro reducing power assay 
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Fig 4: Binding mode of β-sitosterol in the FXR binding pocket (PDB: 1OSH) where β-sitosterol shows H-bond 
interaction between hydrogen of hydroxyl group and oxygen of LEU-352 amino acid 
 
Molecular docking data 
 
β-Sitostirol was subjected for molecular docking 
by calculating the minimum energy to activate 
the target receptor FXR, an important regulatory 
macromolecule whose activation promotes 
hypolipidemic activity. The protein structure file 
(PDB ID: 1OSH) was taken from PDB 
(www.rcsb.org/pdb) and showed the Binding 





In the present study, the effect of the ethanolic 
extract of Prosopis cineraria on experimentally-
induced hyperlipidemia was evaluated in rats. In 
acute oral toxicity study, 70 % ethanolic extract 
of Prosopis cineraria up to the oral dose of 5000 
mg/kg body weight did not produce signs of 
toxicity or mortality in rats. Hence 1/10th of this 
dose was selected as an effective evaluation 
dose (500 mg/kg). Triton WR-1339 is a non-ionic 
detergent and has been widely used to induce an 
acute hyperlipidemia in experimental animals 
[26]. The possible mechanism of action of triton 
is to block the clearance of triglyceride-rich 
lipoproteins by inhibiting the lipoprotein lipase 
[27]. In the present study, the highest levels of 
plasma triglycerides and total cholesterol were 
reached after 24h triton administration compared 
to normal control group. Also, there were 
increase levels of VLDL and LDL along with rise 
in atherogenic index as compared to normal 
control group.  
 
Elevated level of blood cholesterol especially 
LDL-c is a known major risk factor for CHD 
whereas HDL-c is cardio protective [6]. 
Treatment with the extract significantly 
decreased the levels of total cholesterol and 
LDL-c compared to the Triton treated 
(hyperlipdemic) group. Extract treated group also 
showed remarkable reduction in triglyceride and 
VLDL cholesterol compared to triton treated 
group. Hypolipidemic effect of extract increases 
with increase in dose levels. At the highest dose 
levels of 400 mg/dl and 600 mg/dl hypolipidemic 
effect of extract is almost equivalent to standard 
drug simvastatin. Atherogenic index indicates the 
deposition of foam cells or plaque or fatty 
infiltration or lipids in the heart, coronaries, aorta, 
liver and kidneys. The higher the atherogenic 
index, the higher the risk of oxidative damage to 
these organs [28]. This atherogenic index was 
significantly reduced in the Prosopis cineraria 
treated groups compared to triton control group. 
The reduction in atherogenic index at the highest 
dose of extract is almost equal to standard drug 
simvastatin. This may be attributable to plant 
sterols that inhibit the absorption of dietary 
cholesterol and reduce atherogenic index. But 
the resulting decrease in serum cholesterol has 
been slight [9]. Although Prosopis cineraria have 
been shown to contain β-sitosterol using the 
HPLC, β-sitosterol is a plant sterol with a 
structure similar to that of cholesterol, except for 
the substitution of an ethyl group at C24 of its 
side chain. The cholesterol lowering effect may 
be due to this inhibition in reabsorption of 
cholesterol from endogenous sources in 
association with a simultaneous increase in its 
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excretion into feces in the form of neutral 
steroids. Since the results of the study indicated 
that extract has beneficial effect on lipid profile. 
 
The findings of the present study also showed 
that the fruit extract of Prosopis cineraria 
possesses strong free radical scavenging and 
antioxidant activity. Polyphenols other than 
vitamin E have been known to exert powerful 
antioxidant effect in vitro. They inhibit lipid 
peroxidation by acting as chain-breaking peroxyl-
radical scavengers, and can protect LDL from 
oxidation. Phytochemical investigation revealed 
the presence of polyphenols, thus the antioxidant 
effects could be due to presence of these 
phenolic components in the extract [10]. 
 
Further docking study was carried out for the 
target compounds into FXR using GLIDE 
(Schordinger Inc., USA). The crystal structure of 
the enzyme with Fexaramine (PDB: 1OSH) was 
obtained from protein data bank PDB. Our 
compounds were modeled by positioning them in 
the co-crystallized ligand Fexaramine binding site 
in accordance with the published crystal 
structures.  
 
The entire complex was then subjected to 
alternate cycles of minimization and dynamics. 
The intent was to get a satisfactory structure for 
the complex that was consistent with the 
published crystal structure. From the 
comparative docking study of our compounds 
with Fexaramine lead compounds we could 
observe how our compounds might bind to the 
FXR binding site, based on the knowledge of the 
structure of similar active sites. We redocked 
Fexaramine into the active site of the enzyme 
and then we replaced with our compounds in 
order to compare the binding mode of both co-
crystallized ligand and the test compound. These 
docking studies have revealed that the beta-
sitosterol shows H-bonding with Leu-352 amino 
acid backbone with glide score of -8.32 kcal/mol. 
These interactions underscore the importance of 
oxygen as hydrogen bond acceptor for binding 
and the subsequent agonistic capacity. The 
results of this virtual screening support the 
postulation that the active compounds possibly 





The fruits of Prosopis cineraria can be used in 
the treatment of hyperlipidemia which is one of 
the major causes of cardiovascular disease, and 
may serve as a substitute to currently used 
hypolipidemic drugs in the therapy of 
hyperlipidemia. However, long-term studies are 
required to determine the adverse and beneficial 
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